Researcher Christoph Rader spent a decade at the National Cancer Institute in Maryland delving into the intricacy of cancer cells.
Now at Scripps Florida, the biochemist is expanding on that work. Rader is developing anti-cancer treatments that can attack tumors while sparing healthy tissue. He’s also working on ways to recruit a cancer patient’s own T-cells to destroy malignancy.
Scripps Florida this year named Rader associate dean of the Skaggs Graduate School of Chemical and Biological Sciences.